Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for October 2010
October 1, 2010
- GeoVax Presents at AIDS Vaccine 2010 Conference in Atlanta
- Intra-Cellular Therapies Announces Positive Results with ITI-002 in Pre-Clinical Models of Parkinson's Disease
- YM Biosciences To Present Poster On CYT387 At The European School Of Haematology International Conference
- AVEO Pharmaceuticals' Tivozanib Featured at Ninth International Kidney Cancer Symposium
- New Head-to-Head Hypertension Study Shows Benicar Superior to Cozaar
- Phase III Data Showing Improved Survival With Jevtana (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
- Isotechnika Pharma Announces Results Of Confirm1 Trial With Drug Eluting Stent
- Argos Therapeutics' Arcelis Immunotherapy for Renal Cell Carcinoma Demonstrates Encouraging Results in Phase 2 Combination Study With Sunitinib
- VIRxSYS Corporation Demonstrates ?Functional Cure? and Survival Benefit for the simian model of HIV in Preclinical Vaccine Study
- Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Medivir Announces Publication Of Five TMC435 Abstracts For Presentation At The 61st AASLD Meeting
- Idera Pharmaceuticals Announces IMO-2125 Presentation at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
- Merck Announces Pivotal Phase III Data for Boceprevir will be Presented at the American Association for the Study of Liver Diseases 2010 Annual Meeting
- New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease
- Intra-Cellular Therapies Announces Positive Results with ITI-002 in Pre-Clinical Models of Parkinson's Disease
- ZymoGenetics and Bristol-Myers Squibb to Present PEG-Interferon Lambda Phase 2a Interim Clinical Trial Results at AASLD 2010
- ZymoGenetics and Bristol-Myers Squibb to Present PEG-Interferon Lambda Phase 2a Interim Clinical Trial Results at AASLD 2010
- New Data on Multiple Bristol-Myers Squibb Compounds to be Presented at AASLD 2010
October 4, 2010
- Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain
- Photocure announces successful Phase II results for Cevira
- CureVac presents convincing data from the first ever Phase I/IIa clinical study with a mRNA based vaccine
- BioSante Pharmaceuticals, Inc. To Present LibiGel Clinical Trial Update at North American Menopause Society Meeting
- Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients
- VentiRx Pharmaceuticals' Novel TLR8 Agonist, VTX-2337, Successfully Completes Phase 1 Clinical Trial in Oncology
- Celldex Therapeutics Presents Safety and Immunogenicity Data on CDX-1401 at the International Society of Biological Therapy of Cancer Meeting
- Orexigen Therapeutics Announces Upcoming Data Presentations at the 28th Annual Scientific Meeting of The Obesity Society
- Neuraltus Pharmaceuticals Announces Last Patient Out for Studies in ALS and Dyskinesias Associated with the Treatment of Parkinson's Disease
- Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
- Seattle Genetics to Present SGN-75 Clinical Data at the European Society for Medical Oncology (ESMO) Congress
- Human Growth Hormone Shows Promise in Treating Cystic Fibrosis Symptoms
- CrystalGenomics to Present Preliminary Results from Recently Completed Supra-threshold Phase I MAD Study for CG100649, its Novel NSAID Candidate at the Arrowhead 4th Annual Pain Therapeutics Summit
October 5, 2010
- Enzon Announces Publication of Preclinical Study Data of PEG-SN38 in Pediatric Neuroblastoma
- Tom Allen Named Chief Executive Officer of Aubrey Group
- ImmunoCellular Therapeutics' Clinical Data for ICT-107 To Be Featured at World Stem Cell Summit
- Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
- Dynavax's HEPLISAV Demonstrates Superior Seroprotection in Diabetics Compared to Engerix-B
- Third Rock Ventures Appoints Steven Paul, M.D., as Venture Partner
- NKT Therapeutics Announces Hiring of Barbara Finck, M.D. as Chief Medical Officer
- Blood Pressure Pills More Effective When Taken at Night
- Stem Cell Company AmStem Appoints Neuro-Oncology Expert Dr. Michael J. Glantz to Scientific and Medical Board of Advisors
- Adipose-Derived Stem & Regenerative Cells Reduce Mortality, Improve Renal Function in Preclinical Acute Kidney Injury Study Data Published Today
- NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
- Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease
- Otsuka Announces Phase 3 Aripiprazole Intramuscular (IM) Depot Trial Interim Analysis Reveals Efficacy Criteria Met
- African-Americans With High Blood Pressure Need Treatment Sooner, More Aggressively, According to International Medical Group
- Two Pivotal Vectibix Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology
- RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
- NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
- Pharming and Swedish Orphan announce publication of randomized clinical trial results with Pharming's recombinant human C1 inhibitor
- Akebia Announces Postive Phase 2a Results for AKB-6548 for Anemia
- NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
October 6, 2010
- Synergy Pharmaceuticals Announces Positive Phase IIa Results with Plecanatide to Treat Chronic Constipation
- NanoString Technologies Appoints Industry Veteran Barney Saunders, Ph.D., as Chief Commercial Officer
- ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
- Data From Peregrine's Phase II Cotara Brain Cancer Trial to Be Presented at 2010 Congress of Neurological Surgeons Annual Meeting
- Biogen Idec Showcases Global, Multiple Sclerosis Leadership with More Than 45 Data Presentations at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
- Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
- HC&B Healthcare Hires Christina Folger As Associate Interactive Project Manager
- AbelsonTaylor Promotes Elizabeth Resnik, Catherine Blumenfeld and Marisa Izquierdo to Account Executive
- Parisi Named Managing Partner At Ogilvy Commonhealth Worldwide
- Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study
- Aeterna Zentaris Announces Orphan Drug AEZS-130 (Macimorelin, Solorel) Interim Phase 3 Data Analysis Shows Potential for 2011 Filing as Oral Diagnostic Test for Adult Growth Hormone Deficiency (AGHD)
- Limited number of Streptococcus pneumoniae serotypes cause most invasive pneumococcal disease
- FSU researchers examine how bacteria become resistant to antibiotics
- Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
- Researcher at Childrens Hospital Los Angeles Discovers Growth Factor Essential to Epicardial Cell Function and Blood Vessel Formation
- Baxter Presents Data from Interim Analyses of Phase III Clinical Trial of HyQ at European Society for Immunodeficiencies Meeting
- Sarah Holloway Elected to HBA Metro Board
October 7, 2010
- Data on VIVUS' QNEXA to be Presented in Six Posters at The Obesity Society's Annual Meeting
- Spherix Announces Statistically Significant Results in Phase 3 Study With D-tagatose in Type 2 Diabetes
- NephRx Corp. Reports NX002 is Effective in Preclinical Model of Oral Mucositis
- ISCO to Present Data on Progress of Human Parthenogenetic Stem Cell Differentiation into Functional Liver Cells at the Annual Meeting of the American Association for the Study of Liver Diseases
- Depomed Announces Presentations of Breeze 1 and 2 Clinical Data at the North American Menopause Society Annual Meeting
- Oral Tasocitinib Demonstrates Statistically Significant Response by 12 Weeks in Phase 2 Study of People With Moderate to Severe Plaque Psoriasis
- VentiRx Pharmaceuticals Reports Positive Clinical Data for VTX-1463 in Allergic Rhinitis
- Targacept Announces Top-Line Results of Phase 2 Trial of AZD1446 in Adults with ADHD and Provides Update on Status of AZD1446 Development Program
- Teva to Present New Data on Copaxone and Laquinimod at the 26th Annual ECTRIMS Congress
- New Study Published in Journal of Drugs in Dermatology Finds Artefill Effective in Treating Atrophic Acne Scars
- Data Support Hizentra Efficacy, Safety After Dose-Equivalent Switch in Adult and Pediatric Patients with Primary Immunodeficiency
- Privigen Demonstrates Efficacy and Tolerability Among Patients With Various Immunodeficiencies, Data Show
- Study Demonstrates Safety and Efficacy of Subcutaneous Vivaglobin as First-Line Therapy for Primary Immunodeficiency
- Ricerca Biosciences Appoints Eric J. Lubert to Scientific Leadership Role in Biotherapeutics Development
- Intrexon Appoints Former NIH Investigator to Identify High Value Therapeutic Opportunities
- Newly Published Caldolor Clinical Data Demonstrates 77% Reduction in Fever in Hospitalized Patients
October 8, 2010
- PHT Corporation Names Senior Industry Executive Elizabeth Ricci Vice President, Product Development
- GlycoVaxyn Phase I Clinical Study Shows Positive Data with Shigella dysenteriae Vaccine Candidate
- Alnylam Scientists Present New Research on Expanded Delivery of RNAi Therapeutics
- Biocept, Inc. Announces New Director Appointment - September 28, 2010
- Ligand Appoints Sunil Patel to Board of Directors
- Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board
- Researchers at Childrens Hospital Los Angeles Find Diet-Induced Obesity Accelerates Leukemia
- ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial Comparing Trastuzumab-DM1 vs. Standard First-Line Therapy for First-Line HER2+ Metastatic Breast Cancer
- Pilot Clinical Trial Meets Primary Endpoint With Allon's Davunetide
- Celera Says Case-Control Publication on KIF6 Does Not Refute Prior Research on KIF6's Association with Coronary Heart Disease and Statin Benefit
October 11, 2010
- Allos Therapeutics Announces Presentation of Favorable Survival Data from Randomized Phase 2b Study of Folotyn in Patients with Advanced Non-Small Cell Lung Cancer
- Seattle Genetics Reports Preliminary Data from Phase I Clinical Trial of SGN-75
- ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Data for Lorvotuzumab Mertansine at ESMO Annual Meeting
- Phase III Novartis Data Show Potential Benefit of Afinitor Plus Sandostatin LAR In Patients With Advanced Neuroendocrine Tumors
- Presentation at ESMO Highlights Anti-Metastatic Effects of ARQ 197 c-MET Inhibitor in Non-Small Cell Lung Cancer
- ACT BIOTECH Announces Positive Interim Phase 2 Results with Telatinib in First-line Gastric Cancer
- Seattle Genetics and Millennium Announce Positive Top-Line Brentuximab Vedotin (SGN-35) Data from Phase II Trial in Relapsed or Refractory ALCL
- Lilly Presents New Data in Head and Neck Cancer - a Difficult-To-Treat Cancer With Poor Survival Rates
- AVEO Pharmaceuticals' Tivozanib Clinical Data Featured at ESMO
- MuGard Provides Significant Improvement or Stabilization of Oral Mucositis in Over 75% of Patients in European Clinical Experience
- BioSante Pharmaceuticals, Inc. Presents LibiGel Clinical Study Update at North American Menopause Society Meeting
- Optimer Pharmaceuticals Announces Presentations at Upcoming IDSA Annual Meeting
- Melanoma Drug Shrinks Brain Metastases In Phase I/II Study
- Early Tumor Shrinkage with First-line Erbitux Therapy Leads to Longest-Ever Median Survival in KRAS Wild-Type mCRC
- Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
- Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer
- Novocure Reports Data Showing TTF Therapy in Combination With Chemotherapy Has the Potential to Increase Overall Survival for Patients With Advanced Non-Small Cell Lung Cancer
- Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa
- New Afatinib (BIBW 2992) Data in Non-Small Cell Lung Cancer Patients Presented at the 2010 ESMO Congress
- Abbott Reports Psoriasis Phase III Results of its Investigational IL-12/23 Inhibitor Briakinumab (ABT-874)
October 12, 2010
- Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
- Adding Cetuximab to Chemotherapy Doubles Response Rate in Hard-to-Treat Breast Cancer
- Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309
- Afatinib Benefits Lung Cancer Patients Whose Cancer Progressed After Treatment With Egfr Inhibitors
- Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management
- Dynavax to Report New Heplisav Data In Diabetics
- Phase III Study Shows Everolimus Delays Tumor Progression In Hard-to-Treat Neuroendocrine Tumors
- Palonosetron More Effective Than Granisetron In Controlling Nausea According to The Protect Study
- Promising Early Results Suggest Bevacizumab Delays Progression In Newly Diagnosed Ovarian Cancer
- Pazopanib Shows Promise In Phase-Ii Trial for Relapsed/Refractory Urothelial Cancer
- Combination Therapy with Imprime PGG and Erbitux Doubles Overall Response Rate in Colorectal Cancer Clinical Trial
October 13, 2010
- Acceleron Presents Preliminary ACE-031 Results from a Phase 1 Multiple Ascending Dose Study in Healthy Volunteers
- Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management
- First results of three clinical trials of NGR-hTNF presented at ECCO-ESMO 2010
- XenoPort Announces Presentation of Preclinical Data for Novel Fumarate Analog XP23829 at ECTRIMS
- Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine Data
- Helix BioPharma Completes Definitive GLP Toxicology Studies With L-DOS47 and is Making Final Preparations for its Planned Phase I/II Clinical Study IND/CTA Submissions
- Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
- New Evidence That Fat Cells Are Not Just Dormant Storage Depots for Calories
October 14, 2010
- Bayhill Therapeutics to Present Correlation of Antibodies with Clinical Response to Treatment with BHT-3009 in Multiple Sclerosis
- Scientific Paper on Inovio Pharmaceuticals SynCon DNA Vaccines and Intradermal DNA Delivery Technology One of Most Cited Articles in the Journal Vaccine
- Study results show improvement in overall survival for late-stage prostate cancer
- A new option for the treatment of malignant pleural mesothelioma (MPM)
- Everolimus Improves Progression-Free Survival for Patients with Rare Pancreatic Cancer
- Genzyme's Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial
- Florida State Study Finds Watermelon Lowers Blood Pressure
October 15, 2010
- New Study Indicates That Even Delayed Treatment with Oseltamivir Improves Survival in Patients Infected with Avian Influenza (H5N1)
- Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients
- Edimer Pharmaceuticals Presents EDI200 Update to International Gathering of Ectodermal Dysplasia Patient Foundations
- Acorda therapeutics Announces Data On Ampyra (Dalfampridine) Presented at 26th Congress of European Committee for Treatment and Research in Multiple Sclerosis
- Cempra Pharmaceuticals Presents New Data on Its Multi-Drug Resistant Anti-Infective Portfolio, Solithromycin (CEM-101) and TAKSTA(TM) (CEM-102), at The 48th Annual Meeting of The Infectious Diseases Society Of America
- Positive Phase I Data For ZP1848 In Crohn's Disease
- Low Beta Blocker Dose Can Put Patients at Risk for Subsequent Heart Attacks
- UCSB Scientists Discover Inner Workings of Potent Cancer Drug
- Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
October 18, 2010
- Tranzyme Pharma to Present TZP-102 Phase 2 Data Showing Decrease in Severity of Symptoms of Gastroparesis
- Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
October 19, 2010
- Merck presents data on its investigational Cat K Inhibitor, odanacatib
- Data Presented at the American Society for Bone and Mineral Research on Japanese Phase III Study of 'Eldecalcitol,' an Active Vitamin D3 Derivative
- Body's Bacteria Affect Atherosclerosis
- National Stroke Association Survey Reveals More Than Half of Stroke Survivors Suffer Added Burden of Little Known Neurologic Condition
- Pivotal Data Presented at the World Muscle Society Congress Suggest Ataluren Slows the Loss of Walking Ability in Patients with Nonsense Mutation Duchenne/Becker Muscular Dystrophy
- New Study Indicates That Even Delayed Treatment With Oseltamivir Improves Survival in Patients Infected With Avian Influenza (H5N1)
- NovaDel Pharma Inc. Announces Positive Data from Pilot Pharmacokinetic Study Comparing Duromist (sildenafil citrate oral spray) to Viagra Tablet
- Long-Term Data on Cimzia (certolizumab pegol) for Moderate to Severe Crohn's Disease to be Highlighted at ACG Meeting
- Bioniche Scientists Present at Modern Vaccine & Adjuvant Formulation Conference in France
- New Data Evaluating Laquinimod for the Treatment of Multiple Sclerosis Demonstrate Neuroprotective Effects
- Allergy Drug Found to Clear Condition but not Symptoms of Throat Disease
- New Data Evaluating Laquinimod for the Treatment of Multiple Sclerosis Demonstrate Neuroprotective Effects
October 20, 2010
- Aradigm Reports Successful Phase 2b Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin
- Arena Pharmaceuticals Announces Phase 1 Results for APD916 for Narcolepsy with Cataplexy
- Diamyd Trial in Chronic Pain shows Pain Relief
- Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
- New Data Show Therapeutic Benefits in Chronic Rhinosinusitis Patients Using Fluticasone Delivered by OptiNose's Novel Delivery Technology
- Early Initiation of Treatment with Copaxone Provides Greater Effects in Delaying Conversion to Clinically Definite MS
- Neurocrine Biosciences Announces That VMAT2 Program Will Move Into Phase II Clinical Trials
- Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis
- Phase 2b Data Suggest ReVision's Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients
- XIFAXAN 550 mg (Rifaximin) Demonstrates Acute and Sustained Relief of Non-Constipation Irritable Bowel Syndrome Symptoms: Data Presented at the 2010 American College of Gastroenterology (ACG) Annual Meeting
- ImmuPharma plc Update on Phase IIa Clinical Trial with Cancer Compound IPP-204106
- UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease
October 21, 2010
- New Phase 4 Study Shows Higher Rates of Clinical and Microbiological Success for Zyvox Versus Vancomycin in MRSA Nosocomial Pneumonia
- Data Presentations at North American Cystic Fibrosis Conference Highlight Denufosol's Novel Mechanism of Action
- Peregrine Reports Promising Interim Survival Data From Phase II Cotara Brain Cancer Study
- MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint
- Idera Pharmaceuticals Presents Phase 1 Clinical Data for IMO-3100, Lead Candidate for the Treatment of Autoimmune Diseases, and Provides Program Update
- Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo Highway Driving Study
- Transcept Pharmaceuticals to Host Conference Call to Discuss Preliminary Analysis of Intermezzo(R) Highway Driving Study
- Preclinical Studies Show GGF2 Promotes Functional Recovery from Stroke with Treatment Initiated Up to Seven Days After Event
- Alexion Announces Interim Results from Phase 2 Trials of Eculizumab (Soliris) in Patients with atypical Hemolytic Uremic Syndrome (aHUS)
- Gilead's Cayston Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study
- Zalicus Presents Data on Oncology Research at ASCO-NCI-EORTC Meeting
- Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML
- Unigene Reports Top-Level Results on Phase III Study of Oral Calcitonin in Osteoarthritis Patients
- Talecris Biotherapeutics Study Demonstrates PROLASTIN-C is as Effective as PROLASTIN
- ARIKACE Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections in Cystic Fibrosis Patients
- MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
- Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
- In Investigational Study, Zostavax, Merck's Shingles Vaccine, Reduced Incidence of Shingles in Adults Ages 50 to 59 by Nearly 70 Percent
October 22, 2010
- Chimerix's CMX001 Shows Potential for Strong Antiviral Activity in Critically-Ill Immunocompromised Transplant Patients With Adenovirus Infection
- New JUPITER Analysis Demonstrates Crestor (rosuvastatin) Significantly Reduces Major Cardiovascular Events in High Risk Patients
- AMAG Pharmaceuticals, Inc. Announces Data Presentations at the American Society of Nephrology (ASN) Renal Week Meeting
- Revance Therapeutics Announces Clinical Trial Results of RT001 Topical Gel Presented at the Annual Meeting of the American Society of Dermatologic Surgery
- Discovery Labs Announces Presentation & Key Results of Phase 2a Study of Aerosolized KL4 Surfactant in Cystic Fibrosis at the North American Cystic Fibrosis Conference
- Dynavax's Heplisav Demonstrates Superior Seroprotection in Diabetics Compared to Engerix-B - Oct 21, 2010
October 25, 2010
- Seattle Genetics and Millennium to Highlight Brentuximab Vedotin (SGN-35) at the International Symposium on Hodgkin Lymphoma
- Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec in the Prevention of Acute GVHD
- Intercell reports positive results from its Phase II
- Novartis Phase III Study Indicates MF59 Adjuvanted influenza Vaccine, Fluad, Is 75 Percent More Efficacious Than Studied Non-Adjuvanted Vaccines in Young Children
- Phase III Data Show That Novartis Meningococcal Vaccine Menveo Demonstrated Robust Immunogenicity in infants
- Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
- REFLEX Study Results Show Treatment with Rebif Delays Conversion to MS in Patients with First Clinical Signs of the Disease
- Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine
- Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
- NanoBio CEO to Present at the 6th Annual Grand Challenges in Global Health Meeting
- Following Positive Phase II Data, Sanofi Pasteur to Conduct Phase III Trials of Quadrivalent Influenza Virus Vaccine
- ARIAD Announces Interim Results from Randomized Phase 2 Trial of Oral Ridaforolimus in Advanced Endometrial Cancer
- Positive Results From LigoCyte's Norovirus Vaccine Challenge Study Presented at IDSA Annual Meeting
- Alkermes Announces Positive Results from Phase 1 Study of ALKS 33 in Combination with Buprenorphine for Treatment of Cocaine Addiction
- Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
- Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
- Cholesterol-Lowering Drug Shrinks Enlarged Prostates in Hamster Model
October 26, 2010
- Agile Therapeutics Announces Study Results Demonstrating Contraceptive Patch AG200-15 Delivers a Low Dose of Estrogen
- Aeterna Zentaris to Make Poster and Oral Presentations on Highly Selective Erk Inhibitor Compound, AEZS-131, at Major Cancer Conference in Boston
- Oncolytics Biotech Inc. Collaborators Present Data from U.K. Translational Colorectal Cancer Study at the International Symposium on CTL and Immunostimulation
- New Analysis of CAMBIA Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology
- TransPharma Announces Successful Results of a 4 Week Phase 1 Clinical Trial of Its New Self-applied ViaDerm System for the Treatment of Osteoporosis
- Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec in the Prevention of Acute GVHD
- Oramed Pharmaceuticals to Present Results of an Oral Insulin Administration Study at the Tenth Annual Meeting of the Diabetes Technology Society (November 11-13, 2010; Bethesda, MD)
- Medivir?s U.S. commercialisation partner Meda presents positive Xerese data at the AOA's Osteopathic Medical Conference and Exposition
- Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
- Active ingredient Levels Vary Among Red Yeast Rice Supplements
- Immuron Publishes Flu Data in Peer Reviewed Journal
October 27, 2010
- 4SC Announces Initial Phase II Data from the SAPHIRE Study with Resminostat at the 8th International Symposium on Hodgkin Lymphoma
- ENDOMETRIN Vaginal Inserts Demonstrate Comparable Efficacy to Intramuscular Injections of Progesterone-In-Oil for Luteal Support in GnRH IVF Cycles
- 'Possible Key to Alzheimer Medication'
- ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Treating Patients with Crohn's Disease at the United European Gastroenterology Federation (UEGW) Meeting
October 28, 2010
- Ambicare Health Limited Encouraging new independent research on the use of Ambulight PDT to treat skin cancer in Gorlin Syndrome Sufferers
- Investigational Data Presented for INTUNIV (guanfacine) Extended-Release Tablets When Coadministered With Stimulants Showed ADHD Symptom Improvement in Overall, Morning and Evening Assessments
- Rapid Absorption Rate Alone May Not Explain Efficacy in Migraines of Sumatriptan Delivered with OptiNose's Novel Drug Delivery Technology
- Pharmasset Reports Positive Preliminary Antiviral Data with PSI-938 for the Treatment of Hepatitis C
- OctoPlus announces publication of key Phase IIb results for Locteron which confirm Locteron's improved tolerability up to 60 weeks into the SELECT-2 study
- Genetic Variations Associated With Worse Outcomes With Use of Common Antiplatelet Drug For Cardiac Procedures
- Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
October 29, 2010
- Almirall and Forest report preliminary topline results from the ACCORD COPD II Phase III study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
- Abstracts Highlighting Data from Enzon's mRNA Antagonist Programs Accepted for Presentation at 2010 EORTC-NCI-AACR Meeting
- Alnylam Scientists to Present New Data on RNAi Therapeutics at the 61st Annual Meeting of the American Association for the Study of Liver Diseases
- Idera Pharmaceuticals Announces Data Presentation of Proprietary Toll-Like Receptor 3 Agonist Compounds and Their Use as Vaccine Adjuvants
- Medivir to Hold Conference Call and Breakfast Meeting to Discuss TMC435 Data Presented at the 61st AASLD Meeting
- Uncovering the Cause of a Common Form of Muscular Dystrophy
- Abstracts Highlighting Data from Enzon's mRNA Antagonist Programs Accepted for Presentation at 2010 EORTC-NCI-AACR Meeting
- Tryton Presents Positive Six-Month Results for Side Branch Stent System at European Bifurcation Club Meeting
- MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX in FREEDOM-301 Trial
- Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II Phase III Study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Migraine Is Associated With Reduced Household Income and Greater Headache Impact
- Independent Panel Discourages Routine Use of Treatment Regimen for Premature infants
